Spearhead Capital Advisors, LLC Illumina, Inc. Transaction History

Spearhead Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$303.87 - $423.8 $203,592 - $283,946	-670 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$347.28 - $421.83 $347 - $421	-1 Reduced 0.15%	670 $255,000
Q3 2021 Oct 27, 2021	SELL	$405.61 - $524.84 $7,300 - $9,447	-18 Reduced 2.61%	671 $272,000
Q2 2021 Aug 10, 2021	SELL	$372.84 - $481.5 $16,032 - $20,704	-43 Reduced 5.87%	689 $326,000
Q1 2021 Apr 28, 2021	BUY	$361.28 - $504.76 $9,032 - $12,619	25 Added 3.54%	732 $281,000
Q4 2020 Feb 02, 2021	BUY	$292.7 - $370.96 $15,220 - $19,289	52 Added 7.94%	707 $262,000
Q3 2020 Oct 16, 2020	BUY	$268.51 - $400.74 $8,055 - $12,022	30 Added 4.8%	655 $202,000
Q2 2020 Jul 16, 2020	BUY	$256.46 - $373.01 $160,287 - $233,131	625 New	625 $231,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.